Haematology
Dr Michael Lutz appointed as new chief executive officer of iotaSciences
August 18, 2023Business Services Dr Michael Lutz, Haematology, chief executive officer, iotasciences
The pharmaceutical discovery company iotaSciences has announced that it has appointed Dr Michael Lutz as its new chief executive officer. …
Foghorn Therapeutics appoints Alfonso Quintás-Cardama as new chief medical officer
August 18, 2023Business Services Alfonso Quintas-Cardama, Foghorn Therapeutics, Haematology, chief medical officer
The biotechnology company Foghorn Therapeutics has announced the addition of the new chief medical officer, Alfonso Quintás-Cardama, who will be …
FDA approves BioMarin’s Roctavian for adults with severe haemophilia A
June 30, 2023Medical Communications BioMarin, FDA, Haematology, Roctavian, haemophilia
Global biotechnology company BioMarin Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has approved Roctavian (valoctocogene roxaparvocec-rvox) …
Sanofi shares data about new drug for haemophilia A in paediatric patients
June 26, 2023Research and Development Haematology, Sanofi, clinical trial, haemophilia a
Sanofi has shared new data from the phase 3 XTEND-Kids study which assessed Altuviiio (Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein) …
Astellas Pharma and BMT CTN announce phase 3 data for gilteritinib
June 9, 2023Research and Development Astellas Pharma, BMT CTN, Haematology, gilteritinib, leukaemia, pharmaceutical
Japanese pharmaceutical company Astellas Pharma and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) have presented their phase …
Innate Pharma announces drug researched with Sanofi receives FDA Fast Track Designation
June 8, 2023Research and Development Cancer, FDA, Haematology, Innate Pharma, Sanofi, haematology
Innate Pharma has announced that the drug jointly researched between itself and Sanofi has received US Food and Drug Administration (FDA) …
Rocket Pharmaceuticals granted FDA RMAT designation for gene therapy
May 24, 2023Medical Communications FDA, Haematology, RMAT, Rocket Pharmaceuticals, gene therapy
Rocket Pharmaceuticals, a US-based biotechnology company, has announced that it has received US Food and Drug Administration (FDA) Regenerative Medicine …
uniQure announces sale of royalty interest in Hemgenix for up to $400m
May 16, 2023Sales and Marketing Haematology, Hemgenix, haemophilia, royalties, uniQure
uniQure has announced that it has entered a definitive agreement to sell a portion of the royalty rights due to …
